CellVoyant
Robert van Dijk is a Machine Learning Research Scientist at CellVoyant, with experience in using contrastive learning methods to improve image-based profiling workflows. Prior to this, Robert worked as a Visiting Graduate Student at the Broad Institute of MIT and Harvard, focusing on summarizing information from sets of cells. Robert has also been involved in various roles at FruitPunch AI, including as the Head of AI for Health, where Robert connected stakeholders in AI and healthcare, educated them on current healthcare problems and AI technology, and developed projects to address healthcare issues with AI. Robert holds a Master of Science in Engineering in Medical Engineering from Eindhoven University of Technology.
This person is not in any teams
CellVoyant
CellVoyant is an AI-first biotechnology company with a mission to create novel stem cell-based therapies for chronic diseases. Our technology uses AI-first live cell imaging to predict and optimise stem cell differentiation, to controllably manufacture any cell and tissue in the body at scale. CellVoyant is built on foundational work from the Carazo Salas lab at the University of Bristol. We’re working at the exciting intersection of cell biology, computer vision, engineering, and machine learning to industrialise next-generation science from research into the real world. Our mission is bold and ambitious and we have the best investors behind us from day 1. We’re backed by venture capital firms who were the earliest investors in AI pioneer DeepMind, the two leading AI-first drug discovery companies, Exscientia and Recursion, and self-driving challenger Wayve. We’re also supported by the founder/CEO of Abcam, which pioneered the antibody business.